Component

PCOX-1a, a partial cyclooxygenase-1 protein

PCOX-1a, a partial cyclooxygenase-1 protein. Species, exposure and limitations are retained in each linked claim.

1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

Where it participates (unsigned role)

  1. A third distinct cyclooxygenase isozyme, COX-3, made from the cyclooxygenase-1 gene but retaining intron 1 in its messenger RNA, was described as expressed in canine cerebral cortex and as an approximately 5.2 kilobase transcript most abundant in human cerebral cortex and heart, the retained intron introducing an insertion of 30 to 34 amino acids into the hydrophobic signal peptide; canine COX-3 expressed in insect cells possessed glycosylation-dependent cyclooxygenase activity and was selectively inhibited by analgesic and antipyretic drugs such as acetaminophen, phenacetin, antipyrine and dipyrone, so that inhibition of COX-3 could represent a primary central mechanism by which these drugs decrease pain and possibly fever.

    Experimental context and source evidence
    evidence_span
    {"source_cache": "artifacts/paracetamol-research/12242329.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "0c00962f9e58da9af386335ac3312d5c260d637270d80481a6f55d0ebec67a78", "start_char": 0, "end_char": 1711, "text_sha256": "0c00962f9e58da9af386335ac3312d5c260d637270d80481a6f55d0ebec67a78"}
    experimental_model
    Cloning and expression of cyclooxygenase-1-derived transcripts from canine cerebral cortex in insect cells
    exposure
    Canine COX-3 compared with murine cyclooxygenase-1 and -2 against acetaminophen, phenacetin, antipyrine and dipyrone
    limitations
    The paper that proposed the answer. Its activity data are for the canine protein expressed in insect cells; the human claim is about messenger RNA abundance, not about an active protein.
    nutrient_topic
    Paracetamol research collection; topical membership is not evidence of a direct clinical effect, and the drug is recorded separately from the metabolites NAPQI and AM404. · Paracetamol
    organism
    Dog and human
    plain_language
    A third form of the enzyme was reported in dog brain, and it was the one this drug blocked.
    primary_references
    [apap-p12242329] COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. (2002). https://pubmed.ncbi.nlm.nih.gov/12242329/ DOI: 10.1073/pnas.162468699
    tissue_or_cell_type
    Cerebral cortex

    Paracetamol: the enzyme it reduces rather than blocks, the isoform that turned out not to exist, the metabolite that carries the analgesia, and the metabolite that destroys the liver (2026-09-22) · lines 194–205

    AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text. · supports · Cloning and expression of cyclooxygenase-1-derived transcripts from canine cerebral cortex in insect cells · source_derived_draft · unverified_draft

    ### apap-cox3-proposed A third distinct cyclooxygenase isozyme, COX-3, made from the cyclooxygenase-1 gene but retaining intron 1 in its messenger RNA, was described as expressed in canine cerebral cortex and as an approximately 5.2 kilobase transcript most abundant in human cerebral cortex and heart, the retained intron introducing an insertion of 30 to 34 amino acids into the hydrophobic signal peptide; canine COX-3 expressed in insect cells possessed glycosylation-dependent cyclooxygenase activity and was selectively inhibited by analgesic and antipyretic drugs such as acetaminophen, phenacetin, antipyrine and dipyrone, so that inhibition of COX-3 could represent a primary central mechanism by which these drugs decrease pain and possibly fever. Condition category: normal nutrient_topic: Paracetamol research collection; topical membership is not evidence of a direct clinical effect, and the drug is recorded separately from the metabolites NAPQI and AM404. plain_language: A third form of the enzyme was reported in dog brain, and it was the one this drug blocked. organism: Dog and human tissue_or_cell_type: Cerebral cortex experimental_model: Cloning and expression of cyclooxygenase-1-derived transcripts from canine cerebral cortex in insect cells limitations: The paper that proposed the answer. Its activity data are for the canine protein expressed in insect cells; the human claim is about messenger RNA abundance, not about an active protein. exposure: Canine COX-3 compared with murine cyclooxygenase-1 and -2 against acetaminophen, phenacetin, antipyrine and dipyrone evidence_span: {"source_cache": "artifacts/paracetamol-research/12242329.abstract.txt", "locator": "Indexed abstract; zero-based, end-exclusive Unicode character offsets", "file_sha256": "0c00962f9e58da9af386335ac3312d5c260d637270d80481a6f55d0ebec67a78", "start_char": 0, "end_char": 1711, "text_sha256": "0c00962f9e58da9af386335ac3312d5c260d637270d80481a6f55d0ebec67a78"} [apap-p12242329] COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. (2002). https://pubmed.ncbi.nlm.nih.gov/12242329/ DOI: 10.1073/pnas.162468699
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards